Protalix BioTherapeutics, Inc. Common Stock, Value, Issued
Protalix BioTherapeutics, Inc. (PLX) had Common Stock, Value, Issued of $80.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-03-18
- 2025-12-31: Common Stock, Value, Issued $80.00K.
- 2024-12-31: Common Stock, Value, Issued $76.00K.
- 2023-12-31: Common Stock, Value, Issued $73.00K.
- 2022-12-31: Common Stock, Value, Issued $54.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2025-12-31 | $80.00K 10-K · filed 2026-03-18 | |
| 2024-12-31 | $76.00K 10-K · filed 2026-03-18 | |
| 2023-12-31 | $73.00K 10-K · filed 2025-03-17 | |
| 2022-12-31 | $54.00K 10-K · filed 2024-03-14 | |
| 2021-12-31 | $46.00K 10-K · filed 2023-02-27 | |
| 2020-12-31 | $35.00K 10-K · filed 2022-03-31 | |
| 2019-12-31 | $15.00K 10-K · filed 2021-03-30 | |
| 2018-12-31 | $15.00K 10-K · filed 2020-03-12 | $148.00K 10-K · filed 2019-03-18 |
| 2017-12-31 | $144.00K 10-K · filed 2019-03-18 | |
| 2016-12-31 | $124.00K 10-K · filed 2018-03-06 | |
| 2015-12-31 | $100.00K 10-K · filed 2017-03-16 | |
| 2014-12-31 | $94.00K 10-K · filed 2016-03-08 | |
| 2013-12-31 | $93.00K 10-K · filed 2015-03-12 | |
| 2012-12-31 | $93.00K 10-K · filed 2014-03-13 | |
| 2011-12-31 | $86.00K 10-K · filed 2013-02-28 | |
| 2010-12-31 | $81.00K 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |